Oral sodium bicarbonate therapy given to patients with chronic kidney disease increases urinary pH but also increases urinary citrate levels, which may mitigate the risk for calcium phosphate stone formation.
An analysis of contemporary ESA utilization among patients with anemia of nondialysis-dependent chronic kidney disease may help identify optimal candidates for treatment.
The downstream effects of medical care reduction on health outcomes, such as hospitalizations or dialysis preparedness, requires further study, according to the investigators.
Comorbidities and advanced CKD were prevalent among the approximately 275,000 patients with anemia of CKD from the international DISCOVER CKD cohort.
Lack of timely referrals to nephrologists contribute to racial and ethnic disparities in kidney disease care.
Monitoring weight changes and intervening early in patients with CKD, especially those in advanced stages, are warranted, according to investigators.
Patients in eKidneyCare group had fewer total medication discrepancies and a reduction in severity of discrepancies.
Early detection of iron status may improve cardiovascular risk assessment in patients with CKD, according to investigators.
Patient characteristics, such as dialysis use and diabetes status, appeared to be influential factors.
The authors reported that 25 of the total 233 patients included in the study experienced a bleeding event.